Browse Category

Financial Forecasts News 7 December 2025

Rumble Stock (RUM) Today: AI Pivot, Tether Deal and 2026 Forecast After a Wild 2025

Rumble Stock (RUM) Today: AI Pivot, Tether Deal and 2026 Forecast After a Wild 2025

Updated December 7, 2025 Rumble Inc. (NASDAQ: RUM) has spent 2025 reinventing itself from “just” a free‑speech video platform into something much stranger and more ambitious: a crypto‑funded, AI‑infrastructure‑powered media and cloud company. The market is still trying to decide
KSS Stock Outlook 2025: Kohl’s Turnaround Story, Latest News, Forecasts and Analysis as of December 7, 2025

KSS Stock Outlook 2025: Kohl’s Turnaround Story, Latest News, Forecasts and Analysis as of December 7, 2025

Kohl’s Corporation (NYSE: KSS) has turned into one of 2025’s most unpredictable retail stocks. After a brutal start to the year and a “meme‑stock‑style” summer spike, the shares are now trading near their 52‑week highs following a surprise profit, a
INO Stock: Inovio’s FDA BLA Milestone, New Equity Offerings and 2026 Catalyst – Latest News and Forecasts (December 7, 2025)

INO Stock: Inovio’s FDA BLA Milestone, New Equity Offerings and 2026 Catalyst – Latest News and Forecasts (December 7, 2025)

Published: December 7, 2025 Inovio Pharmaceuticals (NASDAQ: INO) has quietly turned 2025 into a make‑or‑break year. The small‑cap biotech has completed a Biologics License Application (BLA) for its lead DNA immunotherapy INO‑3107, raised fresh capital through two stock offerings, and
Merck (MRK) Stock Outlook on December 7, 2025: Price Action, Keytruda Setback, Debt Deal and 2026 Analyst Forecasts

Merck (MRK) Stock Outlook on December 7, 2025: Price Action, Keytruda Setback, Debt Deal and 2026 Analyst Forecasts

Updated: December 7, 2025 Merck & Co., Inc. (NYSE: MRK) — the U.S. pharmaceutical company behind blockbuster cancer drug Keytruda and HPV vaccine Gardasil — has just wrapped up a busy early-December news cycle. The company closed a multi‑billion‑dollar debt
1 30 31 32 33 34 54
Go toTop